Novartis AG is 46.9x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($282.64 B vs $6.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTCT | NVS |
|---|---|---|
| Market cap | $6.03 B | $282.64 B |
| US-listed rank | #1265 | #47 |
| Revenue (latest FY) | $1.73B | - |
| Net income (latest FY) | $683.00M | - |
| Net margin | 39.5% | - |
| P/E (trailing FY) | 8.8 | - |
| SEC filings | 1,262 | 947 |
Novartis AG is 46.9x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($282.64 B vs $6.03 B).
Full pages: PTC THERAPEUTICS, INC. and Novartis AG, or browse the full rankings.